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mportance of Increasing Age on the
resentation and Outcome of Acute
oronary Syndromes in Elderly Patients
avid A. Halon, MB, CHB, FACC, Salim Adawi, MD, Idit Dobrecky-Mery, MD,
asil S. Lewis, MD, FRCP, FACC
aifa, Israel
OBJECTIVES The study examined differences in presentation and outcome between elderly (70 years) and
very elderly (80 years) patients hospitalized for acute coronary syndromes (ACS).
BACKGROUND The elderly constitute an increasingly important sector of patients with ACS but have been
underrepresented in many therapeutic trials.
METHODS We compiled a registry of 449 consecutive patients, 251 elderly (70 to 79 years) (septuage-
narians, group 1) and 198 very elderly (80 years) (group 2), to examine outcomes in relation
to baseline characteristics and treatment. We recorded survival over a period of 24  4
months and rehospitalization and symptomatic status at 16  4 months.
RESULTS At index hospitalization, the older cohort (group 2) more often had acute myocardial
infarction (35% vs. 9.7%, p  0.0001), heart failure (33.3% vs. 19.4%, p  0.001), and renal
dysfunction (21.6% vs. 12.3%, p  0.01). They were less likely to undergo coronary
angiography (29.3% vs. 43.8%, p  0.002), but those selected for angiography more often
underwent revascularization so that revascularization rates were similar (22.7% group 2 vs.
24.3% group 1, p  NS). Two-year survival rate was poorer in group 2 (67.4  3.5% vs.
83.5  2.5% in group 1, p  0.0001). Repeat rehospitalization was similar (53.0% vs. 48.2%,
respectively, p  0.31), but improvement in well-being of survivors was greater (60.0% vs.
46.3%, p  0.01).
CONCLUSIONS The study demonstrated important differences between elderly (70 to 79 years) and very
elderly (80 years) patients hospitalized with ACS. The older cohort was sicker on admission
and had poorer outcome, but a subgroup selected for angiography and possible intervention
had two-year outcomes similar to the younger cohort. (J Am Coll Cardiol 2004;43:346–52)
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ahe elderly constitute an increasing proportion of patients
resenting with acute coronary syndromes (ACS). While
ge itself is a prominent marker of high risk for adverse
vents (1,2), the elderly have usually been underrepresented
n clinical trials of ACS. In studies involving interventional
trategies in the elderly (3), participants were carefully
elected to comply with rigid entry criteria and, therefore,
oorly represent the average patient who often has signifi-
ant comorbid conditions. In a recently published global
egistry of patients with ACS (4), over half the patients were
ver the age of 65 years, emphasizing the growing impor-
ance of examining outcomes in the elderly age group.
Concepts regarding the definition of elderly are changing,
nd it is no longer sufficient to group all patients above a
ertain age cutoff together. Particularly in older patients, an
ge difference of 5 to 10 years may be associated with major
ifferences in biological function. Differences in patient mix
n a “real world” older population may, therefore, have
mportant bearing on the outcomes of clinical trials as well
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Manuscript received June 25, 2003; revised manuscript received August 6, 2003,cccepted August 18, 2003.s the results of routine patient care (4–6). The present
tudy examined outcomes in an unselected cohort of elderly
atients hospitalized for ACS. We investigated differences
n outcome between septuagenarians and patients who were
lder by a decade or more and examined the additional
eterminants of clinical outcome.
ETHODS
atient population. All patients 70 years of age hospi-
alized with an admission diagnosis of ACS in the cardiol-
gy or any of three internal medicine departments in a single
edical center were entered into the Lady Davis Carmel
edical Center geriatric cardiovascular registry. The regis-
ry included 449 consecutive patients: 251 patients age 70 to
9 years (group 1) and 198 patients 80 years (group 2).
roup 2 patients were enrolled during one calendar year
January 1 through December 31, 2000), while those in
roup 1 were enrolled during the same time period, but
ecause this group was considerably larger, six representative
alendar months spaced over the same calendar year were
ampled. The diagnosis of ACS included all patients with
cute or rapidly worsening symptoms thought to be due to
oronary artery disease (CAD) at the time of hospitalization
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February 4, 2004:346–52 Acute Coronary Syndromes in the Elderlynd included patients with ST-elevation acute myocardial
nfarction, non–ST-elevation myocardial infarction, and
atients with unstable angina. Myocardial infarction (AMI)
as recorded when total creatine phosphokinase (CPK) was
2 the upper limit of normal. Unstable angina was
iagnosed in patients on clinical grounds when study criteria
or AMI were lacking but total CPK was above the upper
imit of normal, electrocardiographic changes consistent
ith acute myocardial ischemia were present, or in the
bsence of enzyme or electrocardiographic findings when
atient complaints suggested an ACS. In the majority of
atients in whom unstable angina was diagnosed, there was
levated total CPK or historical or angiographic evidence of
AD (276 of 363, 80.8%). Record was made of interven-
ional procedures, and in-hospital outcomes and symptom-
tic status of survivors was assessed at 16  4 months and
urvival at 24  4 months. Interventional procedures were
ometimes performed after the primary period of hospital-
zation due either to an initial physician instigated strategy
f medical therapy; to patient indecision; or to waiting lists,
articularly for surgical procedures. The definitive therapy
as considered to be interventional if performed within the
alendar year of the registry or no later than one month after
ischarge in patients hospitalized in the last month of the
egistry period. Survival status was obtained for all patients
hrough governmental records or direct patient inquiry by a
tructured telephone interview. Assessment was made of
unctional capacity (New York Heart Association [NYHA]
lassification) and of overall patient well-being. Patient
ell-being was defined as worse, same, better, or much
etter than in the week before index hospitalization. Patient
ecollection of repeat hospitalizations was found to be
nreliable, and repeat hospitalizations in internal medicine,
ardiology, or cardiac surgery departments were recorded
rom health insurance administrative databases. These da-
abases included 90% of all hospitalizations, but over-
eporting of hospitalization could occur due to classification
f some elective day hospital visits and emergency room
isits as full hospitalizations and registration of repeat
ospitalization after weekend home leave.
tatistical methods. Baseline characteristics in the two
roups were examined and compared using 2 2 tables and
hi-squared tests for categorical variables and Student t test
or continuous variables. Difference in time to event distri-
Abbreviations and Acronyms
ACS  acute coronary syndromes
AMI  acute myocardial infarction
CAD  coronary artery disease
CPK  creatine phosphokinase
HF  heart failure
HR  hazard ratio
NYHA  New York Heart Association
PCI  percutaneous coronary interventionutions (death and death or repeat hospitalization) was (xamined using Kaplan-Meier curves and tested using the
og-rank test. Hazard ratios (HR) were estimated using the
ox proportional hazards model. Two-year survival rates
nd 16-month hospitalization-free rates were estimated
sing the Kaplan-Meier method. Binary outcomes were
xamined by logistic regression. Results were summarized
sing odds ratios and 95% confidence intervals (CI). Model
uilding techniques were used to model the distribution of
ime to event from the set of predictors. Due to a large
umber of predictor variables, the stepwise multivariate
rocedure with forward selection was chosen. Initial vari-
bles included significant univariate predictors of outcome
nd important clinical and laboratory variables. Model fit
tatistics of the final model were examined as well as the
roportional hazards assumption (7). A two-tailed proba-
ility of 0.05 was considered to be statistically significant.
ESULTS
aseline characteristics. Baseline characteristics of the
wo patient cohorts are given in Table 1. Mean age was
4.3  2.7 years in group 1 and 84.1  4.0 years in group
. Risk factors for CAD (hypertension, diabetes mellitus)
ere less prevalent in patients in group 2, and the total
holesterol/high-density lipoprotein ratio was lower. The
lder patient cohort had undergone less prior revasculariza-
ion. On the other hand, the prevalence of adverse acute
dmission characteristics such as heart failure (HF) on
dmission, renal failure on admission, and AMI (total CPK
2 the upper limit of normal) was greater. The majority
f patients in both cohorts were classified as non–ST-
levation ACS and were mostly in Braunwald class 3B, but
here was a higher prevalence of noncardiac causes of angina
n the older cohort (Braunwald class A).
nterventional procedures. Coronary angiography was
erformed in 110 (43.8%) of group 1 patients and in 58
29.3%) of group 2 (p  0.002). Selection for coronary
ngiography was based on clinical status and the clinical
udgment of the attending internists and/or cardiologists.
atients selected for angiography were younger (Table 2),
ore frequently male, and more frequently diabetic. More
ad undergone previous PCI. Patients with HF were
atheterized less often. Although undergoing angiography
ess frequently, group 2 patients were more likely to undergo
evascularization after angiography (45, 77.6% vs. 61,
5.5%, p  0.005) so that overall revascularization rates
ere similar in the 2 groups (Table 1). There was a tendency
o a greater use of percutaneous interventional strategies
ather than bypass surgery in group 2 patients, with more
urgical revascularization in the younger cohort despite a
endency to a lower incidence of triple-vessel disease and
ess left main CAD (Table 1).
mmediate and late outcomes. In-hospital mortality was 2
0.8%) in group 1 and 12 (6.1%) in group 2 (p  0.001).
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Acute Coronary Syndromes in the Elderly February 4, 2004:346–52aplan-Meier survival curves and hospitalization-free sur-
ival curves are shown in Figures 1A and 1B, respectively,
nd 2-year survival rates and hospitalization-free survival at
6 months are given in Table 3. Estimated survival at 2
ears for the group as a whole (76.5  2%) and survival free
f repeat hospitalization at 16 months (41.3  2%) were
ow. Survival rate was lower in the older age group (HR 2.3;
Table 1. Baseline Characteristics and Revascul
n
Age (SD)
Hypertension (%)
Diabetes mellitus (%)
Total cholesterol/HDL-C (SD)
Prior revascularization (%)
Prior CVA/TIA (%)
Heart failure at index hospitalization (%)
Renal failure* (SD)
AMI† at index hospitalization (%)
ST elevation AMI
Fibrinolytic therapy
Classification of non–ST-elevation ACS
(Braunwald)‡
I (%)
II (%)
III (%)
A (%)
B (%)
C (%)
Extent of coronary artery disease‡
Coronary angiography performed (%)
1-vessel disease (%)
2-vessel disease (%)
3-vessel disease (%)
Left main coronary artery stenosis (%)
Revascularization (% of patients
undergoing angiography)
Revascularization (% of total patients)
Percutaneous revascularization (% of
revascularization)
*Serum creatinine 1.6 mg/100 ml; †total creatine phospho
ACS  acute coronary syndrome; AMI  acute myoc
high-density lipoprotein cholesterol; TIA  transient ischem
able 2. Characteristics of Patients Undergoing and Not
ndergoing Angiography
Angiography
(n  168)
No Angiography
(n  281) p Value
ge 77.0  4.9 79.6  6.2  0.0001
ale 110 (65.5%) 145 (51.6%) 0.004
eart failure 26 (15.5%) 88 (31.3%) 0.0002
MI 34 (20.2%) 52 (18.5%) NS
iabetes mellitus 59 (35.5%) 74 (26.6%) 0.047
ypertension 113 (67.7%) 199 (71.3%) NS
rior CABG 29 (17.5%) 50 (17.9%) NS
rior PCI 36 (21.6%) 33 (11.8%) 0.006
erum creatinine 1.25  0.55 1.32  0.56 0.16
otal cholesterol/
HDL-C
4.52  1.14 4.63  1.15 NS
MI  acute myocardial infarction; CABG  coronary artery bypass grafting;
DL-C  high-density lipoprotein cholesterol; PCI  percutaneous coronarysntervention.5% CI 1.6 to 3.5; p  0.0001). Repeat hospitalization was
imilar in both groups, but survival free of rehospitalization
as poorer in the older group. Functional capacity (NYHA)
t follow-up was similar in both age groups, although overall
ell-being improved to a greater extent in group 2 (in
elation to that before hospitalization).
Outcomes in relation to treatment modality (medical or
evascularization) and age group are shown in Table 3. In
atients treated medically, the older cohort had a signifi-
antly poorer survival than the younger (HR 2.5; 95% CI
.6 to 3.9; p  0.0001), but, in patients treated by
evascularization, the difference was smaller and not statis-
ically significant (HR 1.6; 95% CI 0.65 to 4.0; p  0.3).
owever, the difference in hazard rates between the revas-
ularization and medically treated cohorts was not signifi-
ant (p  0.52). Rates of repeat hospitalization were similar
etween treatment groups. A greater proportion of surviving
atients in the older cohort reported improvement in overall
ell-being irrespective of treatment modality (Table 3).
eterminants of clinical outcome. Patients selected for
ngiography were found to be an a priori low-risk group.
hey had a higher rate of survival during follow-up irre-
ion Data
9 Years
oup 1
>80 Years
Group 2 p Value
51 198
 2.7 84.1  4.0
(73.5) 129 (65.5) 0.07
(33.4) 50 (25.5) 0.07
 1.2 4.4  1.1 0.04
(35.1) 44 (22.2) 0.003
(7.6) 24 (12.1) NS
(19.4) 66 (33.3)  0.001
(12.3) 41 (21.6) 0.01
(9.2) 63 (31.8)  0.0001
(4.0) 19 (9.6) 0.016
(2.4) 8 (4.0) NS
(1.8) 1 (0.6)
(13.8) 11 (6.7)
(84.3) 151 (92.6) 0.047
(7.4) 26 (16.0)
(91.7) 133 (82.2)
(0.9) 3 (1.9) 0.02
(43.8) 58 (29.3) 0.002
(19.6) 10 (17.2) NS
(25.5) 10 (17.2) NS
(43.1) 33 (56.9) 0.09
(5.9) 9 (16.1) 0.04
(55.5) 45 (77.6) 0.005
(24.3) 45 (22.7) NS
(62.3) 35 (77.8) 0.09
2 upper limit of normal; ‡some data lacking.
infarction; CVA  cerebrovascular accident; HDL-C 
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hospital
Revascularization Medical Therapy
p for
Interaction
/OR*
% CI) 70–79 yrs >80 yrs p Value
HR/OR
(95% CI) 70–79 yrs >80 yrs p Value
HR/OR
(95% CI)
61 45 190 153
2.3
6–3.5)
86.9  4.3 75.2  7.3 0.3 1.6
(0.65–4.0)
82.3  3.0 64.8  4.1  0.0001 2.5
(1.6–3.9)
0.52
1.3
0–1.7)
49.0  6.4 37.2  7.3 0.14 1.5
(0.88–2.4)
44.0  3.8 35.8  4.2 0.07 1.3
(0.98–1.7)
0.70
0.82
0–1.2)
26 (42.6) 24 (53.3) 0.28 0.65
(0.3–1.4)
86 (45.3) 81 (52.9) 0.16 0.74
(0.48–1.1)
0.79
1.3
2–2.0)
29 (60.4) 11 (32.4) 0.01 3.2
(1.3–8.0)
62 (40.8) 45 (42.1) 0.83 0.95
(0.56–1.6)
0.02
0.59
7–0.91)
30 (61.2) 29 (76.3) 0.14 2.0
(0.80–5.2)
65 (41.7) 55 (53.9) 0.05 0.61
(0.37–1.0)
0.69
2.5
4–4.3)
13 (26.5) 0 (0)  0.001 — 52 (33.3) 22 (21.6) 0.04 1.8
(1.0–3.2)
—
elderly vs. very elderly); †at 16 months; ‡proportion of live patients available for follow-up.
ociation; OR  odds ratio. 349
JACC
Vol.43,No.3,2004
Halon
et
al.
February
4,2004:346–52
Acute
Coronary
Syndrom
es
in
the
Elderlytw
o-year
survival
84.6

2%
in
those
selected
for
raphy
vs.
71.6

2%
for
those
not
selected,
p

.
In
patients
undergoing
diagnostic
angiography
t
subsequent
revascularization,tw
o-year
survivalrate
.7

4%
(p

0.016
vs.
patients
not
selected
for
raphy).
O
verall
survival
rate
after
revascularization
tsignificantly
differentfrom
thatin
m
edically
treated
ts
(74.7

2%
in
patients
treated
m
edically
vs.82.3


0.18).
variate
predictors
of
death
and
death
or
repeat
hos-
ation
are
show
n
as
H
R
s
and
95%
C
Is
in
Figures
2A
,respectively.H
eart
failure
on
adm
ission
(tw
o-year
l
rate,
51

5%
vs.
85.1

2%
;
p

0.0001)
and
serum
creatinine
(60.3

6%
tw
o-year
survival
rate
.
K
aplan-M
eier
curves
of
(A
)
survival
and
(B
)
survival
free
of
ization
for
septuagenarian
and
octogenarian
patients.
Table 3. Outcomes in Relation to Treatment Modality
Overall Group
70–79 yrs >80 yrs p Value
HR
(95
n 251 198
Survival rate (%)
(2 yrs)
83.5  2.5 67.4  3.5  0.0001
(1.
Hospitalization-free
survival rate (%)†
45.3  3.2 36.1  3.7 0.02
(1.
Repeat hospitalization,
n (%)
121 (48.2) 105 (53.0) 0.31
(0.6
Improved/class 1
(NYHA), n (%)‡
91 (45.5) 56 (39.7) 0.29
(0.8
Improved well-being, n
(%)
95 (46.3) 84 (60.0) 0.01
(0.3
Deteriorated well-being,
n (%)
65 (31.7) 22 (15.7)  0.001
(1.
*Hazard ratio for survival/event-free survival rates, odds ratio for binary outcomes (
CI  confidence interval; HR  hazard ratio; NYHA  New York Heart Ass
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Acute Coronary Syndromes in the Elderly February 4, 2004:346–52or patients with serum creatinine1.5 mg% vs. 78.7 2%
ith creatinine 1.5 mg%, p  0.001) and AMI predicted
oorer two-year survival rate (AMI 60.4  6% vs. 80.3 
%, p  0.0001). This was most apparent in the younger
ohort in which two-year survival rate was 65.2  10% in
atients with AMI compared with 85.4  3% in those
ithout (p  0.003) and directionally similar in the older
ohort in which two-year survival rate was 58.3  7% in
atients with AMI and 71.7  4% in those without (p 
.08). The interaction of AMI with age tended to signifi-
ance (p  0.15); AMI on admission was a predictor of
oorer survival in both the revascularization and the medi-
ally treated cohorts. In the revascularization cohort, sur-
ival rate was 57.7 7% in patients with AMI on admission
ersus 78.2  3% in those without AMI (p  0.03), and in
atients treated medically alone 66.8  9% in patients with
MI on admission versus 88.3  4% in those without (p 
.0001). There was no interaction of revascularization with
MI (p  0.76). The increased overall risk in patients with
MI was primarily the result of poorer survival in the first
ix months after the acute event, whereas, during later
ollow-up, the increased risk diminishes considerably. Sur-
igure 2. Univariate predictors of (A) death (24 months) and (B) death/r
CE  angiotensin-converting enzyme; BB  beta blocker; Ca  calciu
VA/TIA  cerebrovascular accident/transient ischemic attack; FC (N
DL-C high-density lipoprotein cholesterol; MImyocardial infarctio
otal cholesterol.ival rate was higher in patients discharged on statin therapy itwo-year survival 82.7  3% vs. 75.2  3%, p  0.04),
hose selected for treadmill testing (100  0% vs. 74.1 
%, p  0.0005) or coronary angiography (as reported
bove), and those who had undergone previous percutane-
us coronary intervention (PCI) (86.7  4% vs. 74.5  2%,
 0.02).
A multivariate regression model was constructed to ex-
mine predictors of death and included the univariate
redictors of death: older age, HF on admission, admission
erum creatinine, AMI, poorer functional capacity (NYHA)
efore admission, lack of selection for exercise stress test,
nd lack of selection for coronary angiography. Also in-
luded were clinical variables such as sex, diabetes mellitus,
istory of hypertension, prior revascularization, and current
evascularization therapy. Predictors of death in the final
odel were older age group (HR 2.1; 95% CI 1.4 to 3.1;
 0.001), admission HF (HR 3.2; 95% CI 2.1 to 4.8; p
.001) and poorer functional capacity (NYHA) before
ospital admission (HR 1.5 for each grade of functional
apacity; 95% CI 1.1 to 2.0; p for trend 0.006), and lack of
election for exercise stress testing (100% survival in patients
elected for test). An additional similar model examined
hospitalization (16 months) (hazard ratios  95% confidence intervals).
BG  coronary artery bypass grafting; CAD  coronary artery disease;
)  functional capacity (New York Heart Association classification);
I percutaneous coronary intervention; revasc revascularization; TCepeat
m; CA
YHA
n; PCndependent predictors of death or repeat hospitalization.
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February 4, 2004:346–52 Acute Coronary Syndromes in the Elderlycute myocardial infarction (HR 1.7; 95% CI 1.3 to 2.3; p
0.001), poorer prior functional capacity (HR 1.4 per
rade; 95% CI 1.2 to 1.7; p for trend 0.001), and diabetes
ellitus (odds ratio 1.3; 95% CI 1.0 to 1.7; p  0.03) were
ignificant in the final model.
Verification of the proportional hazards assumption with
egard to the identified risk factors was established using
ime-dependent covariates (7). Global (overall) chi-squared
tatistic of the final model for survival was 92.99 and for
ospitalization-free survival 29.723 with 4 degrees of free-
om for both (p  0.0001 for both models), indicating that
he identified risk factors can be used to predict survival
ime.
ISCUSSION
his study focused on the contrasts between elderly (septu-
genarians) and very elderly (octogenarians and older) pa-
ients hospitalized for ACS. An increase of 10 years of age
as associated with a doubling of mortality rate at 24
onths (33% vs. 17%, p  0.001). Although at the time of
ospitalization octogenarians were more ill than the septu-
genarians, a low-risk subgroup of octogenarians was se-
ected for coronary angiography with a two-year survival
ate of 76  6% (75  7% in those undergoing revascular-
zation) approaching that of the younger cohort not selected
or angiography (79  4% two-year survival rate). Symp-
omatic improvement was experienced by the majority of
atients in both age groups selected for intervention but in
uch fewer of those not selected (Table 3). Few studies
ave directly compared age substrata within a group of
lderly patients. The American College of Cardiology-
ational Cardiovascular Data Registry showed that, among
ctogenarians undergoing PCI, age was a progressive pre-
ictor of adverse outcome (8,9) as in other nomograms
redicting outcome (10,11). The present study had the
dvantage of examining an unselected cohort of consecutive
lderly patients in a registry rather than those selected for
nterventions or selected by stringent inclusion/exclusion
riteria (3). As a single-center study, it was possible to
nsure that all elderly patients with ACS hospitalized within
given time period were included, thus avoiding selection
ias, which may play a role with the less exact reporting that
ay occur in multicenter registries.
Patients presenting with ACS in their 80s were sicker on
dmission to hospital as manifested by a greater prevalence
f HF, AMI, renal failure, and, in those undergoing
ngiography, more extensive coronary disease (three-vessel,
eft main coronary disease). Similar findings were described
n elderly patients in both percutaneously and surgically
reated patients (8,12–14). Surviving patients in the older
ohort experienced a greater improvement in overall well-
eing, and this was in keeping with two other studies (3,15).
In the American College of Cardiology National Cardio-ascular Data Registry, octogenarians undergoing PCIithin a week of AMI had higher in-hospital mortality than
hose without AMI (7). The present study also found a
igher overall late mortality in patients presenting with
MI both in the revascularization and medically treated
ohorts. In a comparison of cohorts of elderly patients after
MI with a high and low intervention rate, one-year
ortality was similar (16). A recent trial selecting patients at
igh risk for bypass surgery for randomization to PCI or
urgery (including age 70 years as one high-risk criterion)
17) found almost identical survival rates in the two treat-
ent cohorts at 36 months. Longer postoperative hospital-
zation was reported in elderly patients (18). A report of
ypass surgery in 11 nonagenarians reported an in-hospital
urvival of 82% with improvement in quality of life in
urvivors but high in-hospital morbidity (19). In the present
tudy, mortality was not significantly different in patients
reated medically or undergoing revascularization. Among
atients undergoing revascularization, late mortality was
imilar after PCI or bypass surgery.
Lack of selection for exercise testing (and for angiogra-
hy) were independent predictors of mortality. Also signif-
cant as an independent predictor of death or repeat hospi-
alization was a poorer functional capacity before the acute
vent leading to hospitalization. These data confirm the
mportance of straightforward clinical assessment and sound
linical judgment as predictors of mortality and as correlates
f outcome in elderly patients.
The study has the limitations of a single-center registry in
hat findings may be influenced by local patient referral and
hysician practice patterns and, therefore, need to be con-
rmed in additional patient cohorts. A registry study does
ave the advantage of representing real world clinical
ractice, and the findings of the study are probably appli-
able to a large number of tertiary health care facilities.
erum troponin was not available at the time of the study.
f available, this would have allowed better definition of the
cute characteristics of the patient cohorts because a con-
iderable proportion of patients with normal total CPK
alues would probably have been troponin-positive. There
ave been some changes in emphasis in treatment options
ince the registry data were recorded. A relatively small
roportion of patients had ST-elevation myocardial infarc-
ion (partially due to referral bias), and the number treated
ith fibrinolytic therapy was relatively small due to very late
rrival in some patients. Primary angioplasty was not per-
ormed in this patient cohort (although percutaneous rescue
nterventions were). Primary angioplasty is more frequently
erformed at the present time.
ummary. The registry provides a picture of the character-
stics and outcomes in unselected elderly and very elderly
atients with ACS. The elderly are sicker on admission and
ave poorer outcome, but a subgroup selected for angiog-
aphy and possible intervention have two-year outcomes
imilar to their younger counterparts.
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